WEDNESDAY, Dec. 28, 2022 (HealthDay News) — China plans to roll back some of its strict COVID-19 controls, including allowing more of its people to travel abroad.
During the pandemic, the country has limited passports, allowing them only for family emergencies or some work travel, but the government announced Tuesday that it will begin taking applications for tourism passports on Jan. 8, the Associated Press reported. The National Immigration Administration of China will also take applications to extend, renew, or reissue visas, noting that the agency has not said when it might take applications for new visas.
As the news hit, travel companies said they experienced a surge in website searches for visa information and international ticket bookings to places, including to the United States. Other popular sites were Japan, Thailand, South Korea, Great Britain, and Australia.
China is currently experiencing a COVID-19 surge, the AP reported. Reports from cities have suggested that the ongoing COVID-19 wave in China has infected tens and possibly hundreds of millions of people and could lead to between 1 million and 2 million deaths in that country through late 2023.
Some countries, including Japan and India, have started requiring travelers from China to undergo COVID-19 tests for the virus. South Korea tests travelers if they have elevated temperatures, the AP reported, requiring a one-week home or hotel quarantine for anyone who tests positive. The country may build on those measures in an announcement expected Friday. Taiwan will start testing visitors from China on Jan. 1.
China’s government has ceased reporting nationwide COVID-19 case numbers, and took it off the list of illnesses that require quarantining. Officials also plan to stop tracking close contacts. The country intends to “gradually resume” admitting foreign visitors, though it is not clear when that will happen. It may not be until mid-next year, the AP reported. China also plans to stop requiring foreign travelers to quarantine starting Jan. 8.
Copyright © 2022 HealthDay. All rights reserved.